Biologics and Biosimilars

Dissimilar to with nonexclusive medications of the more regular little particle sort, biologics typically display high sub-atomic multifaceted nature, and might be very delicate to changes in assembling forms. despite the fact that they do have admittance to the popularized moderniser item. Generally speaking, it is firmer to find out fungibility amongst generics and trend-setters among biologics than it is among completely integrated and semisynthesized arrangements, which is the reason the name "biosimilar" was begat to separate these arrangements from little particle generics.

  • Immunoassays
  • Spectrometry
  • Biosimilar Research Pipelines
  • Globalization of Biosimilars
  • Upcoming Challenges In Biosimilars
  • Biosimilars Analytical Strategies
  • Biological Drugs And Biowaivers

Related Conference of Biologics and Biosimilars

September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Conference and Exhibition on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Biologics and Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in